Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-379-2 | CAS number: 68815-51-0
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50, rat: > 2000 mg/kg bw
Acute dermal toxicity: LD50, rat: > 2000 mg/kg bw
Acute inhalation toxicity: There are no data available concerning acute inhalation toxicity.
Key value for chemical safety assessment
Additional information
Oral:
In the key study that was performed according to OECD guideline 423 in compliance with GLP in male and female Sprague-Dawley rats the LD50 was determined to be > 2000 mg/kg bw (BASF AG, 2007). No mortality occured. The only observed clinical sign was slight piloerection shortly after dosing. Nothing abnormal was detected concerning body weight and gross pathology.
Dermal:
In the key study that was performed according to OECD guideline 402 in compliance with GLP in male and female Wistar rats the LD50 was determined to be > 2000 mg/kg bw (BASF SE, 2009). No mortality occured. No systemic clinical signs were observed during clinical examination. The mean body weight of the female animals did not adequately increase during the first post-exposure observation week, probably due to the bandage procedure, but increased during the second week. The mean body weight of the male animals increased throughout the study period. No macroscopic pathologic abnormalities were noted in the animals (5 males and 5 females) examined on the last day of observation. Local skin effects (erythema, edema, scaling and encrustations) were observed one day after application of the substance through to the end of the observation period.
Inhalation:
There are no data available concerning acute inhalation toxicity.
Justification for classification or non-classification
GHS classification according to Annex I 1272/2008 CLP (EU GHS):
- Oral route: conclusive, but not sufficient for classification
- Dermal route: conclusive, but not sufficient for classification
- Inhalation route: data lacking
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
